While ApoA-IV has been implicated in certain neurodegenerative and psychiatric disorders, its stability in the CSF of GBS and CIDP patients suggests that its potential influence is not universal across all neurological diseases [162]. This evidence concerns the gene APOA4 and chronic inflammatory demyelinating polyradiculoneuropathy.